Grant winners – 5 November 2015

A round-up of recent recipients of research council cash

November 5, 2015
Grant winners tab on folder

Royal Society

Wolfson Research Merit Awards

These awards are worth £10,000-£30,000 a year, which is a salary enhancement

Tuneable lasers for optical coherence tomography and their translation


Unlocking the biotechnological potential of the subsurface


Understanding and exploiting immune recognition of cellular stress


Stochastic modelling for improving understanding of storm risk


National Institute for Health Research

Efficacy and Mechanism Evaluation Programme

A blinded randomised controlled trial investigating the efficacy of morphine analgesia for procedural pain in infants


Public Health Research Programme

A woman-centred, tailored SMS-delivered multi-component intervention for weight loss and maintenance of weight loss in the postpartum period: intervention adaptation and pilot RCT


Health Technology Assessment Programme

QUIDS: quantitative fibronectin to help decision-making in women with symptoms of preterm labour


Medical Research Council

Research grants

MICA: Investigating the pathogenic role of T follicular helper cells and their therapeutic targeting in primary Sjögren’s syndrome


Human mechanosensation: from first-order neurone to somatosensory cortex


Optogenetic dissection of homeostatic and Hebbian components of cortical plasticity


In detail

Award winner: Matthew Wood
Institution: University of Oxford
Value: £1,008,110

Exosome-based gene therapy for Huntington’s disease

Despite being comparatively rare, this neurodegenerative disease nevertheless affects one in 10,000 people in the UK. Huntington’s disease puts a huge burden on patients and their families, and there is currently no cure. This is largely because of the inability of therapeutic compounds to cross the blood-brain barrier and enter affected parts of the brain at levels sufficient for clinical benefit. While therapeutic compounds are being developed to treat Huntington’s disease, their delivery into the brain is the major hindrance to their becoming treatments that could be widely used. Over 36 months, the team will develop a new treatment, which can switch off the mutant Huntingtin gene, and cross the blood-brain barrier to enter the brain using small, natural particles called exosomes. This will open the door to testing compounds that have been proven to reduce the levels of the Huntingtin gene. If successful, the method could be used to treat many other currently incurable neurodegenerative diseases.

You've reached your article limit

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 6 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments

Featured Jobs

Research Assistant LONDON SCHOOL OF ECONOMICS & POLITICAL SCIENCE LSE
Lecturer in University Study Skills UNIVERSITY OF HAFR AL BATIN
Lecturer in English Language UNIVERSITY OF HAFR AL BATIN

Most Commented

question marks PhD study

Selecting the right doctorate is crucial for success. Robert MacIntosh and Kevin O'Gorman share top 10 tips on how to pick a PhD

India, UK, flag

Sir Keith Burnett reflects on what he learned about international students while in India with the UK prime minister

Pencil lying on open diary

Requesting a log of daily activity means that trust between the institution and the scholar has broken down, says Toby Miller

Application for graduate job
Universities producing the most employable graduates have been ranked by companies around the world in the Global University Employability Ranking 2016
Construction workers erecting barriers

Directly linking non-EU recruitment to award levels in teaching assessment has also been under consideration, sources suggest